Market News AIOpen the app

SXTP stock news · 60 Degrees Pharmaceuticals, Inc.

Stories about 60 Degrees Pharmaceuticals, Inc. (SXTP) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for SXTP

Follow 60 Degrees Pharmaceuticals, Inc. (SXTP) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SXTP
Free on the App Store and Google Play, or on the web.
  1. Oct 6, 2026, 7:48 AM ET · Market

    60 Degrees Pharmaceuticals, Inc. shared new information about babesiosis that could affect how investors feel.

    Neutral

    60 Degrees Pharmaceuticals updated its investor presentation and announced an update to a January 2027 data readout. The filing gives no new results or specific date, so it does not change the company's outlook.

  2. Oct 6, 2026, 5:11 AM ET · Market

    Shares of 60 Degrees Pharmaceuticals dropped 6% before the market opened as people wait for tafenoquine trial results.

    Neutral

    SXTP plans to release early tafenoquine trial results Tuesday, but the report gives no findings. It does not change the company's prospects yet.

  3. Oct 5, 2026, 5:16 PM ET · Market

    Here are 12 health care stocks that changed in value after the market closed on Monday.

    Neutral

    60 Degrees shares rose in after-hours trading. The report gives no business reason for the move, so it does not change the company's outlook.

  4. Sep 8, 2026, 4:32 PM ET · Paperwork

    60 Degrees Pharmaceuticals, Inc. shared a new investor presentation with the SEC for upcoming meetings.

    Neutral

    60 Degrees Pharmaceuticals, Inc. filed a Form 8-K with the SEC to disclose an updated investor presentation intended for use in meetings with investors and analysts.